Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- MyOme
- Study ID
- NCT06542432
- Status
- Enrolling By Invitation
Conditions
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease
- Heart Diseases
- Myocardial Infarction
- Polygenic Risk Score
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Disclosure of integrate risk score for coronary artery disease — GENETICParticipants will receive their integrated risk score for coronary disease along with an optional genetic counseling visit to discuss the results.
Study Details
The goal of this study is to assess the benefit to physicians and patients of adding an integrated risk score (IRS) to existing coronary artery risk tools by conducting a randomized prospective study. IRS combines both an individual's coronary artery disease (CAD) polygenic risk score (PRS) and clinical risk factors, like cholesterol levels and age. This study will examine to what extent IRS knowledge impacts physician/provider behavior as well as clinical outcomes including cholesterol levels and incident heart disease.
Key Dates
- Start date
- Jan 1, 2025
- Status verified
- Sep 2025
- Primary completion
- Jul 1, 2029
- Completion
- Jul 1, 2029
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Experimental: InterventionParticipants will receive their integrated risk score result for coronary artery disease.
- No Intervention: No Intervention: ControlParticipants will only receive standard of care ASCVD Pooled Cohorts Equation (ASCVD PCE), and disclosure of integrated risk score result will be deferred until 3 years after enrollment.
Primary Outcome Measure
Does receiving an IRS report influence clinical decision making, including the provider's decision to treat with lipid lowering medication or order diagnostic testing? [ Time Frame: 5 years ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
Find similar trials in Rochester, MN
Related Studies
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- Is Our Microbiome a Predictor of Cardiac RiskEnrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Mayo AVC Registry and BiobankRecruiting · Mayo Clinic · Rochester, Minnesota
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona